Medicinal Nicotine for Preventing Cue Induced Craving

Completed · Not applicable · Has a placebo group

Conditions studied: Tobacco Use Disorder

In brief

The purpose of this study is to determine if changing the timeframe (relative to cue presentation) at which the nicotine lozenge is given can attenuate the increase in symptoms of tobacco craving and withdrawal that occur when smokers are presented with smoking cues. In this cross-over study, all subjects attend three laboratory sessions at which either nicotine lozenge or placebo is given prior to presentation of smoking cues or after presentation of smoking cues. The order in which the three conditions will be presented are randomized.

Key facts

Study ID

NCT02347605

Run by

University of Minnesota

People needed

56

Starts

2013-09-01

Expected to finish

2015-01-01

Last updated by the study team

2017-12-18

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Smoking a minimum number of cigarettes per day
• General good health

You may not qualify if…

• unstable medical or psychiatric conditions
• history of severe motion sickness (due to virtual reality equipment used to present cues)
• women who are pregnant or breast feeding
• The investigators will evaluate if there are other reasons why someone may not participate

Where it is running

• Clinical and Translational Sciences Institute — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.